amiodarone has been researched along with Chronic Lung Injury in 8 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone is an antiarrhythmic drug which is used to treat and prevent several dysrhythmias." | 2.58 | A case report and literature review: previously excluded tuberculosis masked by amiodarone induced lung injury. ( Abramavicius, S; Kadusevicius, E; Karinauske, E; Musteikiene, G; Pilvinis, V; Stankevicius, E; Zaveckiene, J, 2018) |
| "Treatment of amiodarone pulmonary toxicity consists primarily of stopping amiodarone." | 2.46 | Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect? ( Berghaus, T; Haeckel, T; Schwaiblmair, M; von Scheidt, W; Wagner, T, 2010) |
| "for 4 weeks to induce pulmonary injury in rats and OM-treated groups received 0." | 1.43 | Impact of Olmesartan Medoxomil on Amiodarone-Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor-ß1. ( Abd Allah, OM; Sharaf El-Din, AA, 2016) |
| "There were 7 cases of drug-induced lung injury, 3 caused by amiodarone, and the other 4 caused by interferon-alpha, atorvastatin, carbamazepine, and propylthiouracil respectively." | 1.34 | [Clinicopathological manifestations of drug-induced lung injury]. ( Liu, HR; Shi, JH; Xu, WB; Yan, XW; Zhu, YJ, 2007) |
| "Amiodarone-induced lung injury has characteristic pathologic features which may provide clues to diagnosis." | 1.33 | [Clinicopathologic manifestation of amiodarone-induced lung injury]. ( Liu, HR; Shi, JH; Xu, WB; Zhu, YJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Radwan, SM | 1 |
| Ghoneim, D | 1 |
| Salem, M | 1 |
| Saeed, M | 1 |
| Saleh, Y | 1 |
| Elhamy, M | 1 |
| Wael, K | 1 |
| Shokair, O | 1 |
| Wahdan, SA | 1 |
| Karinauske, E | 1 |
| Abramavicius, S | 1 |
| Musteikiene, G | 1 |
| Stankevicius, E | 1 |
| Zaveckiene, J | 1 |
| Pilvinis, V | 1 |
| Kadusevicius, E | 1 |
| Sharaf El-Din, AA | 1 |
| Abd Allah, OM | 1 |
| Vatutin, NT | 1 |
| Shevelyok, AN | 1 |
| Degtiarova, AE | 1 |
| Taradin, GG | 1 |
| Gricenko, YP | 1 |
| Vasilenko, IV | 1 |
| Schwaiblmair, M | 1 |
| Berghaus, T | 1 |
| Haeckel, T | 1 |
| Wagner, T | 1 |
| von Scheidt, W | 1 |
| Shi, JH | 2 |
| Liu, HR | 2 |
| Zhu, YJ | 2 |
| Xu, WB | 2 |
| Yan, XW | 1 |
2 reviews available for amiodarone and Chronic Lung Injury
| Article | Year |
|---|---|
A case report and literature review: previously excluded tuberculosis masked by amiodarone induced lung injury.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Giant Cell Arteritis; Humans; Lung Injury; Male; Respirato | 2018 |
Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug-Related Side Effects and Adverse Reac | 2010 |
6 other studies available for amiodarone and Chronic Lung Injury
| Article | Year |
|---|---|
Adipose Tissue-Derived Mesenchymal Stem Cells Protect Against Amiodarone-Induced Lung Injury in Rats.
Topics: Actins; Adipose Tissue; Amiodarone; Animals; Cell Proliferation; Fibroblast Growth Factor 7; Flow Cy | 2020 |
Impact of Olmesartan Medoxomil on Amiodarone-Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor-ß1.
Topics: Amiodarone; Animals; Collagen Type I; Disease Models, Animal; Dose-Response Relationship, Drug; Drug | 2016 |
[The Development of Pulmonary Damage When Receiving Amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lung Injury; Middle Aged | 2016 |
Occasionally, I have atrial fibrillation. I hate it, but I hate taking medications, too. My doctor wants me to go on amiodarone. Can you tell me if it has any side effects? I need to decide which is worse--the problem or the medication?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Lung Injury; Pneumonia; Pulmonary F | 2010 |
[Clinicopathologic manifestation of amiodarone-induced lung injury].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Follow-Up Studies; Glucocorticoids; Humans; Lung; | 2006 |
[Clinicopathological manifestations of drug-induced lung injury].
Topics: Adolescent; Adult; Amiodarone; Female; Humans; Lung; Lung Injury; Male; Middle Aged; Tomography, X-R | 2007 |